Eli Lilly's next-gen anti-obesity candidate hit it out of the park in a phase 3 study. This should help solidify the ...

Eli Lilly ( LLY 2.00%) recently announced stellar results from a phase 3 clinical trial, Triumph-4, which evaluated efficacy ...

Eli Lilly ( LLY 1.19%) and Novo Nordisk ( NVO 2.44%) are two of the leading companies in the fast-growing GLP-1 weight loss ...

Eli Lilly could extend its lead in its core therapeutic area with the launch of two new products next year. The company also ...

Eli Lilly 's (NYSE: LLY) share price has soared over the past five years (up 530%). In fact, it's hard to find a single ...

We came across a bullish thesis on Eli Lilly and Company on Pebble Bites’s Substack by Christina Gan. In this article, we ...

INDIANAPOLIS, Oct. 30, 2024 /PRNewswire/ -- Eli Lilly and Company (LLY) today announced its financial results for the third quarter of 2024. "Lilly had another strong growth quarter in Q3, with total ...

(Reuters) - U.S. drugmaker Eli Lilly on Monday said it has appointed insider Lucas Montarce as its new chief financial officer, effective immediately, months after former CFO Anat Ashkenazi stepped ...

Eli Lilly and Co. on Monday elevated a company insider to chief financial officer, succeeding Anat Ashkenazi, who left three months ago to join Google and Alphabet. Lucas Montarce, who has been with ...

Three months after announcing that EVP and CFO Anat Ashkenazi would be leaving for another opportunity, Eli Lilly and Company has named a replacement. The pharma giant promoted Lucas Montarce to lead ...

For Jacob Van Naarden, Executive Vice President and President of Lilly Oncology, the mission is clear: bring better cancer ...